| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Angiogenesis inhibitors in combinatorial approaches
|
Nowak-Sliwinska, Patrycja
|
|
2017
|
20 |
2 |
p. 183-184
|
article
|
| 2 |
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
|
Ramjiawan, Rakesh R.
|
|
2017
|
20 |
2 |
p. 185-204
|
article
|
| 3 |
Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer
|
Kuusk, Teele
|
|
2017
|
20 |
2 |
p. 205-215
|
article
|
| 4 |
Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists
|
Bani, MariaRosa
|
|
2017
|
20 |
2 |
p. 233-241
|
article
|
| 5 |
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
|
Berndsen, Robert H.
|
|
2017
|
20 |
2 |
p. 245-267
|
article
|
| 6 |
Erratum to: Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists
|
Bani, MariaRosa
|
|
2017
|
20 |
2 |
p. 243-244
|
article
|
| 7 |
miRNAs: micro-managers of anticancer combination therapies
|
Beijnum, Judy R. van
|
|
2017
|
20 |
2 |
p. 269-285
|
article
|
| 8 |
The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
|
Hamming, Lisanne C.
|
|
2017
|
20 |
2 |
p. 217-232
|
article
|
Journal description